This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Home Nutrition Support Team Interventions Prevent Hospitalizations, Reduce Costs For Clinical Nutrition Patients

Home nutrition support team interventions improved patient care and potentially prevented more than 429 hospital days over a three-month period, according to new data presented by Walgreens Infusion Services (NYSE: WAG) (Nasdaq: WAG) at the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Clinical Nutrition Week meeting today in Phoenix. The cost savings of these interventions were estimated at more than $850,000.

The study included data from 16 Walgreens Infusion Services offices, with 2,500 enteral nutrition (EN) patients (who received their nutrition needs through a feeding tube) and 270 parenteral nutrition (PN) patients (who received their nutrition intravenously) on service during the study period. Interventions were performed by the Walgreens Infusion Services home nutrition support team, which includes nurses, pharmacists and dietitians who work closely with physicians to provide care to PN and EN patients. This patient-centric multidisciplinary approach to care enabled the teams to quickly identify therapy complications and intervene to address them with the guidance of the physicians. There were 165 total interventions completed during the three-month study, including correcting over/underfeeding, preventing dehydration, reducing/eliminating diarrhea, managing hyperglycemia, managing electrolyte imbalances, transitioning patients from PN to oral eating, and starting patients on PN therapy in the home (instead of in the hospital).

“Dietitians are experts in nutrition support and play a vital role in home-delivered care,” said Noreen Luszcz, RD, MBA, CNSC, Walgreens Infusion Services nutrition program director. “Our home nutrition support teams work together to proactively monitor patient’s therapy and provide regular updates to the patient’s physician. We invest in having dietitians as part of our teams because they play a vital role in providing appropriate, safe, cost-effective home nutrition support.”

Patients are typically prescribed PN or EN because they cannot absorb an adequate amount of nutrients due to a health condition like cancer, a stroke or surgical complications. While both therapies can be administered in the hospital, about 40,000 PN patients and 344,000 EN patients each year receive their nutrition therapy at home, where they are more comfortable and can avoid the risk of exposure to hospital-acquired infections. 1,2

The poster including these data, presented at Clinical Nutrition Week today, was one of the three top-scoring posters in the Home and Alternate Site Care Section for the meeting. For more information or to receive a copy of the poster, which includes details about the number of specific interventions performed for each group, please contact bculbertson@pcipr.com.

About Walgreens Infusion Services

Walgreens Infusion Services is the nation’s largest provider of home and alternate treatment site infusion services. With a staff of more than 1,400 clinical experts – including specially trained infusion nurses, infusion pharmacists and registered dietitians – Walgreens Infusion Services treats patients with a wide range of acute and chronic conditions. Comprehensive therapy management programs are offered for patients with nutrition disorders, bleeding disorders and heart failure, as well as those needing immunoglobulin (IG) therapy, anti-infective therapy and transplant services. Patients are supported 24/7 through more than 75 infusion pharmacies and 100 alternate treatment sites across the country.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs